Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

142 Press Releases
DateTitleCompany
02 May 16 Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company,
Published by
PR Newswire
12 Apr 16 Lilly to Provide Detailed Update of Pipeline and R&D Strategy at Upcoming Investment Community Meeting Eli Lilly and Company,
Published by
PR Newswire
04 Apr 16 Lilly Confirms Date and Conference Call for First-Quarter 2016 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
18 Mar 16 Eli Lilly's stock drops sharply again, to lead health care sector lower Eli Lilly,
Published by
PharmiWeb.com
03 Mar 16 CHMP Recommends Approval of Lilly’s Ixekizumab [TALTZ®] for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company ,
Published by
PharmiWeb.com
26 Feb 16 Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company,
Published by
PR Newswire
12 Feb 16 UK Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit Eli Lilly and Company,
Published by
PR Newswire
11 Feb 16 Lilly Diabetes Helps Inspiring Students with Type 1 Diabetes Attend College Through Scholarship Donation Eli Lilly and Company,
Published by
PR Newswire
05 Feb 16 American Diabetes Association® Survey Shows Summer Camp Can Positively Impact Children's Disease Management Skills, Confidence and Stress Eli Lilly ,
Published by
PharmiWeb.com
27 Jan 16 Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool Eli Lilly and Company,
Published by
PR Newswire
27 Jan 16 https://investor.lilly.com/releasedetail.cfm?releaseid=951493 Eli Lilly ,
Published by
PharmiWeb.com
27 Jan 16 U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin) Eli Lilly ,
Published by
PharmiWeb.com
18 Dec 15 FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment Eli Lilly ,
Published by
PharmiWeb.com
15 Dec 15 Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results Eli Lilly and Company,
Published by
PR Newswire
15 Dec 15 Juan R. Luciano elected to Lilly board of directors Eli Lilly and Company,
Published by
PR Newswire
11 Nov 15 Patients Show Significant Improvement in Signs and Symptoms of Psoriatic Arthritis, Less Progression of Structural Joint Dama... Eli Lilly and Company,
Published by
PharmiWeb.com
11 Nov 15 Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis Eli Lilly and Company,
Published by
PharmiWeb.com
04 Nov 15 Lilly to Participate in Credit Suisse 2015 Healthcare Conference Eli Lilly and Company,
Published by
PR Newswire
02 Nov 15 Eli Lilly and Company Announces Expansion of Indianapolis R&D Headquarters Eli Lilly and Company,
Published by
PR Newswire
23 Jul 15 Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew Eli Lilly,
Published by
PharmiWeb.com
14 Jul 15 Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes Eli Lilly and Company,
Published by
PR Newswire
22 Jul 15 Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease Eli Lilly and Company,
Published by
PR Newswire
22 Jul 15 Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease Eli Lilly ,
Published by
PharmiWeb.com
23 Jul 15 Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center Eli Lilly ,
Published by
PharmiWeb.com
23 Jul 15 Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance Eli Lilly ,
Published by
PharmiWeb.com
13 Oct 15 Lilly and ImaginAb Announce Preclinical Immuno-Oncology Collaboration Eli Lilly and Company,
Published by
PR Newswire
06 Oct 15 Lilly to Showcase Data for Investigational Psoriasis Treatment at 24th European Academy of Dermatology and Venereology Congress Eli Lilly and Company,
Published by
PR Newswire
07 Oct 15 Lilly Confirms Date and Conference Call for Third-Quarter 2015 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
08 Oct 15 Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer Eli Lilly and Company,
Published by
PR Newswire
09 Oct 15 Eli Lilly and Company Expands New York City Research and Development Site Eli Lilly and Company,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.